1. The disrupted molecular circadian clock of monocytes and macrophages in allergic inflammation.
- Author
-
Teppan J, Schwanzer J, Rittchen S, Bärnthaler T, Lindemann J, Nayak B, Reiter B, Luschnig P, Farzi A, Heinemann A, and Sturm E
- Subjects
- Humans, Animals, Male, Hypersensitivity immunology, Hypersensitivity metabolism, Inflammation immunology, Female, Mice, Adult, Pyroglyphidae immunology, Cells, Cultured, Circadian Rhythm immunology, Monocytes immunology, Monocytes metabolism, Circadian Clocks immunology, Macrophages immunology, Macrophages metabolism, Asthma immunology, Asthma metabolism
- Abstract
Introduction: Macrophage dysfunction is a common feature of inflammatory disorders such as asthma, which is characterized by a strong circadian rhythm., Methods and Results: We monitored the protein expression pattern of the molecular circadian clock in human peripheral blood monocytes from healthy, allergic, and asthmatic donors during a whole day. Monocytes cultured of these donors allowed us to examine circadian protein expression in human monocyte-derived macrophages, M1- and M2- polarized macrophages. In monocytes, particularly from allergic asthmatics, the oscillating expression of circadian proteins CLOCK, BMAL, REV ERBs, and RORs was significantly altered. Similar changes in BMAL1 were observed in polarized macrophages from allergic donors and in tissue-resident macrophages from activated precision cut lung slices. We confirmed clock modulating, anti-inflammatory, and lung-protective properties of the inverse ROR agonist SR1001 by reduced secretion of macrophage inflammatory protein and increase in phagocytosis. Using a house dust mite model, we verified the therapeutic effect of SR1001 in vivo ., Discussion: Overall, our data suggest an interaction between the molecular circadian clock and monocytes/macrophages effector function in inflammatory lung diseases. The use of SR1001 leads to inflammatory resolution in vitro and in vivo and represents a promising clock-based therapeutic approach for chronic pulmonary diseases such as asthma., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Teppan, Schwanzer, Rittchen, Bärnthaler, Lindemann, Nayak, Reiter, Luschnig, Farzi, Heinemann and Sturm.)
- Published
- 2024
- Full Text
- View/download PDF